INTERBRI · CHINA MARKET ACCESS FOR MEDICAL DEVICES China-focused support. Clear scope. Accountable coordination.
Class II · Registration

Class II Medical Device Registration Requirements and Dossier

Registration managementOverseas applications go to NMPACertificates valid for 5 years

Class II medical devices are of moderate risk and require stricter controls to ensure safety and effectiveness, so they are subject to registration management: applications pass through acceptance, technical review and administrative approval, and products may only be marketed after a registration certificate is issued — valid for 5 years. Applications for overseas products are submitted to the National Medical Products Administration (NMPA). This page compiles the structure of the registration dossier, the formal requirements for imported products and practical points, so you can plan the submission with a "right the first time" mindset.

I. The Six Sections of a Registration Dossier

Under the current submission requirements, the registration dossier is organized under six primary headings, each with clearly defined secondary headings:

Table: I. The Six Sections of a Registration Dossier
SectionMain Contents
1. Regulatory InformationTable of contents, application form, glossary and abbreviations, product list, associated documents, pre-submission communications with the authority, declaration of conformity
2. Overview DocumentationOverview, product description, intended use and contraindications, marketing history, other explanations
3. Non-clinical DocumentationRisk management documentation, essential principles of safety and performance checklist, product technical requirements and test reports, research documentation, non-clinical literature, stability studies
4. Clinical Evaluation DocumentationClinical evaluation documentation (route selection below)
5. Instructions for Use and LabelingInstructions for use, labeling samples
6. Quality Management System DocumentationOverview, manufacturing information, QMS procedures, management responsibility, resource management, product realization, measurement/analysis/improvement procedures, QMS verification documents

This structure is the skeleton of all documentation work. We recommend building the dossier framework and responsibility split around the six sections before drafting — it prevents documents from contradicting each other and keeps review communication disciplined.

II. Formal Requirements for Imported Products

Beyond content, the submission dossier for imported products carries explicit formal requirements:

  • Table of contents & binding — the dossier shall include a table of contents (primary and secondary headings); documents under each secondary heading shall be paginated separately; arranged in catalogue order and bound into a volume;
  • Copies & paper — one copy of the dossier (two copies for the Product Technical Requirements), printed on A4 paper, complete, legible and free of alterations; documents issued by government or other institutions in their original dimensions; bound volumes shall not be disassembled;
  • Chinese language — except for associated documents, all documents shall be provided in Chinese. Foreign-language supporting documents require a Chinese translation signed/stamped by the domestic agent; documents translated from foreign-language materials shall be submitted together with the originals;
  • Photocopies & consistency — photocopies shall be legible and consistent with the originals; the application information across all documents shall be consistent.

III. Signature, Seal & Notarization

  • Division of signatures — original-language documents are signed/stamped by the overseas registration applicant (legal representative or person in charge signing, or signing plus the organization's seal); Chinese-language documents are signed/stamped by the domestic agent (official seal, or the legal representative/person in charge signing plus the official seal);
  • Notarization — for imported products, the associated documents, declaration of conformity, instructions for use and labels provided by the overseas applicant shall be submitted as notarized copies issued by a notary institution in the applicant's jurisdiction. Electronic notarization is acceptable, provided an explanatory document from the overseas applicant about the new process is also submitted.
Start the notarization chain early: it involves overseas notaries, agent stamps and translation coordination, and its lead time is often underestimated — one of the most common bottlenecks in imported dossiers.

IV. Electronic Document Requirements

In addition to the paper dossier, the following shall also be submitted electronically:

  • Application form;
  • Product Technical Requirements — Word format, editable;
  • Overview documentation, non-clinical study overview and instructions for use — Word format, editable;
  • Clinical trial database — appropriate formats by file type (PDF, Word, Excel, XPT, TXT, etc.), with Word/Excel/TXT files editable.

V. Clinical Evaluation Pathways

Not every Class II product needs a clinical trial. China runs risk-based, multi-pathway clinical evaluation: products listed in the catalogue of products exempt from clinical evaluation may rely on non-clinical data; same-variety clinical evaluation argues safety and effectiveness by comparison with marketed equivalents; where a clinical trial is genuinely needed, eligible products may use overseas clinical data in accordance with regulations. The pathway directly affects timeline and cost — decide it early in submission planning.

VI. How INTERBRI Helps

  • Submission planning — building the dossier framework around the six sections with key milestones and preparation order;
  • Documentation system — checking completeness and cross-document consistency, coordinating translation;
  • Notarization & signatures — orchestrating overseas notarization, agent stamps and Chinese translations;
  • Submission & follow-up — coordinating submission, tracking acceptance and review progress, relaying feedback.

Planning a Class II registration?

Send us your product information — we will help confirm the classification and pathway, and build a feasible submission plan.

About Our Initial Registration Service
This page is compiled from current regulatory requirements for reference only and does not constitute legal advice; the specific requirements are subject to the latest provisions of China's medical device authorities and the documents applicable at acceptance.

Examples of Class II medical devices in China

Class II covers moderate-risk devices that need stricter control. Illustrative examples include: electronic thermometers, blood pressure monitors and blood glucose meters; ECG machines and ultrasound equipment; nebulizers and home oxygen concentrators; hearing aids; surgical microscopes; and sterile surgical masks. As with every class, the official Classification Catalogue governs the actual class; where the catalogue is unclear, a classification determination confirms it. See our China medical devices overview.

Class II vs. Class III registration: key differences

The registration mechanics are similar, but the reviewing authority and risk level differ. Domestic Class II devices are reviewed by the provincial drug regulatory department; domestic Class III devices and all imported Class II and Class III devices are reviewed by NMPA, with technical review performed by the Center for Medical Device Evaluation (CMDE). Both certificates are valid for five years. The higher the class, the more the review focuses on clinical evidence and quality-system depth. If you are placing a higher-risk product on the market, see Class III requirements.

How to confirm your device’s management class

China sorts medical devices into three classes by risk. The authoritative source is the official Medical Device Classification Catalogue published by NMPA, which lists many product families together with their management class and example names. If your product is not listed, or its class is uncertain, you can apply for a classification determination (分类界定): new or unlisted products and uncertain imported products are submitted to the NMPA Standardization and Management Center, while uncertain domestic products go to the provincial authority. In practice, check the catalogue first and, where it is unclear, confirm the route with the competent authority before preparing the dossier. Our China medical devices overview and the classification catalogue guide set out the working approach.

Frequently asked questions

QWhat is the difference between Class II and Class III registration?

Both require registration, but the reviewing authority differs: domestic Class II is reviewed by the provincial drug regulatory department, while domestic Class III and all imported Class II/III devices are reviewed by NMPA, with technical review performed by CMDE. Both certificates are valid for five years. The higher the class, the more the review emphasises clinical evidence and quality-system depth. See Class III requirements.

QDoes Class II require a clinical trial?

Not necessarily. Many Class II devices can be registered through clinical evaluation using literature and data of a predicate (same-type) device. A clinical trial is required only when existing clinical data are insufficient to demonstrate safety and effectiveness. Whether a trial is needed is decided case by case on the dossier and product risk. See our clinical evaluation guide.

QHow long is a Class II registration certificate valid?

Five years from the date of issuance. Before expiry, a renewal application must be submitted — see Class II & III renewal.

QCan a Class II device be upgraded to Class III?

If the risk profile increases (for example through a significant design or intended-use change), the device may need to be registered as Class III; this is handled as a change registration or a new registration depending on the circumstances — see change registration.

Back to China Medical Devices